Rapid Serological Tests and Immunity Policies: Addressing Ethical Implications for Healthcare Providers and the Healthcare System as a Priority

Abstract

Healthcare providers (HCP) have been central actors in containing the COVID-19 pandemic Although potentially very beneficial, the implementation of large-scale rapid serological tests raises ethical dilemmas and affects HCPs' capacity to work in optimal conditions In this regard, we call for attention to address specific and urgent ethical issues distinctively affecting HCPs following the availability and possible mandatory use of rapid serological tests for COVID-19 © 2020 University of Montreal All rights reserved